Stock Events

Haleon 

$4.01
10
-$0.06-1.43% Monday 19:58

Statistics

Day High
4.1
Day Low
4.1
52W High
5
52W Low
0.2
Volume
603
Avg. Volume
4,534
Mkt Cap
38.83B
P/E Ratio
0
Dividend Yield
1.13%
Dividend
0.05

Upcoming

Dividends

1.13%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

29FebExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
0
10.32
20.65
30.97
Expected EPS
0.0445
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HLNCF. It's not an investment recommendation.

About

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Show more...
CEO
Employees
24622
Country
GB
ISIN
GB00BMX86B70
WKN
000A3DNZQ

Listings